CSL Behring Medical Expert Portal is a European webpage designed for healthcare professionals who are interested in serious and life-threatening conditions. Register and login to access the information on this webpage and to receive updates when new content becomes available.

Disclaimer: due to compliance regulations, not all content of this webpage is intended for UK healthcare practitioners. If you would like to access UK specific materials on this site, please reach out to your local CSL Behring medical representative (medinfo@cslbehring.com) for assistance.

Disclaimer

CSL EXPERT HIVE

Webinars on-demand

Gene therapy 2: HEMGENIX® clinical practice

Pathology:

Haemophilia A Haemophilia B

Watch the full video recording of the second instalment of the two-part HEMGENIX®: The journey from science to clinical practice webinar, Part 2: What are the impacts on clinical practice? held on May 22, 2023.

This webinar was moderated by Frank Leebeek (The Netherlands) and featured presentations from Niamh O’Connell (Ireland), Daan Breederveld (The Netherlands), Shingirai Mutamba (UK), Margaret Nolan (Ireland) and Robert Klamroth (Germany).

The faculty described the processes of eligibility assessment and shared decision-making for patients and healthcare providers considering HEMGENIX® as a potential therapy. This was followed by a description of what happens on the infusion day, including the coordination of the multidisciplinary team from the perspective of a pharmacist and nurse. Finally, the long- and short-term follow-up considerations for patients who received HEMGENIX® are described.

Please note that this webinar contains information on specific products and indications. Please refer to Summary of Product Characteristics available on www.ema.europa.eu for detailed information on HEMGENIX®.